Ohcanbohtosat - F C Cheng

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    Maximum acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer.

    Maximum acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer. Dahkki F C Cheng, Shiu‐Kum Lam, G. B. Ong

    Almmustuhtton 1977
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bioengineering tools for next-generation neural organoids

    Bioengineering tools for next-generation neural organoids Dahkki Richard O’Laughlin, F. C. Cheng, Hongjun Song, Guo‐li Ming

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)

    609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prosta... Dahkki Ben Tran, Lisa G. Horvath, Tanya B. Dorff, M. Rettig, Martijn P. Lolkema, J-P. Machiels, Sylvie Rottey, Karen A. Autio, Richard Greil, Nabil Adra, Charlotte Lemech, Mukul Minocha, F-C. Cheng, Hosein Kouros‐Mehr, Karim Fizazi

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) retreatment (RTx) after recovery from grade (Gr) 1 interstitial lung disease/pneumonitis (ILD)

    267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) retreatment (RTx) after recovery from grade (Gr) 1 interstitial lung disease/pneumonitis (ILD) Dahkki H. S. Rugo, Eriko Tokunaga, Hiroji Iwata, Vanessa Petry, Egbert F. Smit, Y. Goto, Dong‐Wook Kim, Kohei Shitara, James F. Gruden, Shanu Modi, J. Cortés, IE Krop, P.A. Jänne, Yun Cheng, Corina Taitt, F-C. Cheng, CA Powell

    Almmustuhtton 2024
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    162O Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing advanced breast cancer

    162O Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing... Dahkki E. Hamilton, Charles L. Shapiro, Valentina Boni, M. Martín Jiménez, Gianluca Del Conte, J. Cortés, Laila Agrawal, H-T. Arkenau, Antoinette R. Tan, Philip R. Debruyne, Anna Minchom, Annemie Rutten, F. Valdes-Albini, Evan Y. Yu, Fumitaka Suto, F-C. Cheng, Bincy Augustine, Bi‐Hua Cheng, Daniel Barrios, S.A. Hurvitz

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: